Rapamycin Treatment for Activated Phosphoinositide 3-Kinase δ Syndrome
Clinical trial NCT03383380 · COMPLETED
Trial details
- NCT number
- NCT03383380
- Sponsor
- Children's Hospital of Fudan University
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-01
- Primary completion
- 2022-11-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.